CJ
AQST icon

Caitlin John’s Aquestive Therapeutics AQST Stock Holding History

Caitlin John’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.54K Sell
2,300
-500
-18% -$2.03K 0.01% 530
2025
Q4 		$18.1K Sell
2,800
-100
-3% -$623 0.01% 454
2025
Q3 		$16.2K Buy
+2,900
New +$12.5K 0.01% 430
2025
Q1 		– Sell
-5,900
Closed -$21K – 168
2024
Q4 		$21K Sell
5,900
-500
-8% -$2.31K 0.01% 370
2024
Q3 		$30.9K Buy
6,400
+2,200
+52% +$8.56K 0.02% 311
2024
Q2 		$10.9K Buy
+4,200
New +$14K 0.01% 447

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caitlin John's AQST Position: Q1 2026 in Review

Caitlin John reduced its Aquestive Therapeutics (AQST) stake by 18% in Q1 2026, selling an estimated $2.03K and leaving 2,300 shares worth $9.54K. The position accounts for 0.01% of the portfolio, ranked #530.

Caitlin John first reported a position in AQST in Q2 2024 and has held it in 6 quarters since. The position peaked at $30.9K in Q3 2024. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Caitlin John held 2,300 shares of Aquestive Therapeutics worth $9.54K as of Q1 2026.
  • Caitlin John sold 500 Aquestive Therapeutics shares in Q1 2026, an estimated $2.03K.
  • Aquestive Therapeutics made up 0.01% of Caitlin John's portfolio in Q1 2026, its #530 holding.
  • Caitlin John first reported a position in Aquestive Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Caitlin John's Aquestive Therapeutics position peaked at $30.9K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.